Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 14 | 2018 | 592 | 0.810 |
Why?
|
| Cultural Diversity | 1 | 2021 | 158 | 0.720 |
Why?
|
| Hawaii | 27 | 2020 | 1878 | 0.720 |
Why?
|
| Body Mass Index | 10 | 2018 | 775 | 0.660 |
Why?
|
| Long QT Syndrome | 2 | 2010 | 12 | 0.640 |
Why?
|
| Insulin Resistance | 1 | 2019 | 177 | 0.610 |
Why?
|
| Glucose Intolerance | 2 | 2007 | 42 | 0.600 |
Why?
|
| Aging | 3 | 2020 | 639 | 0.570 |
Why?
|
| Cross-Sectional Studies | 19 | 2021 | 2561 | 0.550 |
Why?
|
| Electrocardiography | 6 | 2020 | 154 | 0.540 |
Why?
|
| Prevalence | 14 | 2021 | 1425 | 0.510 |
Why?
|
| Middle Aged | 35 | 2020 | 9642 | 0.470 |
Why?
|
| Aged | 25 | 2020 | 6448 | 0.450 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 881 | 0.420 |
Why?
|
| Male | 40 | 2020 | 18870 | 0.420 |
Why?
|
| Adult | 25 | 2021 | 11034 | 0.400 |
Why?
|
| Diabetes Mellitus | 5 | 2009 | 465 | 0.390 |
Why?
|
| Rural Health | 2 | 2007 | 45 | 0.360 |
Why?
|
| Obesity | 6 | 2014 | 965 | 0.350 |
Why?
|
| Humans | 45 | 2021 | 34853 | 0.350 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 105 | 0.350 |
Why?
|
| Female | 37 | 2020 | 19873 | 0.340 |
Why?
|
| Sweat Glands | 1 | 2007 | 2 | 0.320 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2007 | 3 | 0.320 |
Why?
|
| Sweating | 1 | 2007 | 5 | 0.320 |
Why?
|
| Risk Factors | 15 | 2020 | 3414 | 0.310 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 24 | 0.300 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 19 | 0.300 |
Why?
|
| Mass Screening | 1 | 2010 | 427 | 0.280 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 165 | 0.280 |
Why?
|
| Blood Glucose | 4 | 2009 | 333 | 0.250 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 2333 | 0.240 |
Why?
|
| Age Factors | 3 | 2019 | 1007 | 0.210 |
Why?
|
| Niacin | 2 | 2013 | 23 | 0.210 |
Why?
|
| Health Status Disparities | 2 | 2020 | 583 | 0.210 |
Why?
|
| Sleep Apnea, Central | 1 | 2020 | 4 | 0.190 |
Why?
|
| Atrial Flutter | 1 | 2020 | 7 | 0.190 |
Why?
|
| Regression Analysis | 5 | 2010 | 429 | 0.190 |
Why?
|
| Coronary Disease | 1 | 2020 | 113 | 0.180 |
Why?
|
| Autonomic Nervous System | 2 | 2012 | 36 | 0.180 |
Why?
|
| Sex Factors | 4 | 2020 | 859 | 0.180 |
Why?
|
| Hypertension | 3 | 2005 | 770 | 0.170 |
Why?
|
| HIV Infections | 4 | 2013 | 2207 | 0.160 |
Why?
|
| Feeding Behavior | 4 | 2009 | 418 | 0.160 |
Why?
|
| Odds Ratio | 4 | 2008 | 517 | 0.160 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 964 | 0.140 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 841 | 0.140 |
Why?
|
| Cohort Studies | 7 | 2018 | 1422 | 0.140 |
Why?
|
| Glucose Tolerance Test | 3 | 2015 | 66 | 0.130 |
Why?
|
| Logistic Models | 4 | 2009 | 894 | 0.130 |
Why?
|
| Body Size | 1 | 2014 | 28 | 0.130 |
Why?
|
| Blood Pressure | 3 | 2011 | 613 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 528 | 0.110 |
Why?
|
| World Health Organization | 2 | 2010 | 30 | 0.110 |
Why?
|
| Lipoproteins | 1 | 2013 | 61 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 413 | 0.110 |
Why?
|
| Health Surveys | 4 | 2011 | 358 | 0.110 |
Why?
|
| Comorbidity | 3 | 2018 | 606 | 0.110 |
Why?
|
| Adolescent | 8 | 2011 | 5035 | 0.110 |
Why?
|
| Population Surveillance | 2 | 2010 | 231 | 0.100 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 423 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2011 | 12 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 139 | 0.100 |
Why?
|
| Viremia | 1 | 2011 | 40 | 0.100 |
Why?
|
| Population Groups | 1 | 2011 | 56 | 0.100 |
Why?
|
| Anthropometry | 2 | 2012 | 91 | 0.100 |
Why?
|
| Cellulitis | 1 | 2010 | 7 | 0.100 |
Why?
|
| Methicillin Resistance | 1 | 2010 | 12 | 0.100 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2010 | 9 | 0.100 |
Why?
|
| Adiposity | 1 | 2012 | 145 | 0.100 |
Why?
|
| Quality of Life | 2 | 2006 | 459 | 0.100 |
Why?
|
| Asia | 2 | 2020 | 74 | 0.100 |
Why?
|
| Life Style | 5 | 2014 | 288 | 0.100 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 24 | 0.100 |
Why?
|
| Prejudice | 1 | 2011 | 101 | 0.090 |
Why?
|
| Japan | 2 | 2011 | 296 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 87 | 0.090 |
Why?
|
| Vasodilation | 1 | 2010 | 65 | 0.090 |
Why?
|
| Philippines | 2 | 2006 | 72 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2011 | 137 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 58 | 0.090 |
Why?
|
| Dietary Fiber | 1 | 2009 | 42 | 0.090 |
Why?
|
| Diet | 3 | 2014 | 747 | 0.090 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 6 | 0.090 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2009 | 20 | 0.090 |
Why?
|
| Magnesium | 1 | 2009 | 95 | 0.090 |
Why?
|
| Sex Distribution | 4 | 2014 | 212 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 424 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2014 | 311 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 393 | 0.080 |
Why?
|
| Depression | 2 | 2006 | 664 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 358 | 0.080 |
Why?
|
| California | 4 | 2011 | 436 | 0.080 |
Why?
|
| Reflex | 1 | 2007 | 31 | 0.080 |
Why?
|
| Energy Intake | 1 | 2008 | 160 | 0.080 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2007 | 13 | 0.080 |
Why?
|
| Rheumatology | 1 | 2007 | 15 | 0.080 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 32 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2006 | 60 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 491 | 0.070 |
Why?
|
| Axons | 1 | 2007 | 106 | 0.070 |
Why?
|
| Introns | 1 | 2006 | 67 | 0.070 |
Why?
|
| Blood Flow Velocity | 2 | 2003 | 63 | 0.070 |
Why?
|
| Rural Population | 2 | 2007 | 253 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2006 | 87 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2006 | 155 | 0.070 |
Why?
|
| Pediatrics | 1 | 2007 | 66 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2007 | 110 | 0.070 |
Why?
|
| Acculturation | 1 | 2008 | 172 | 0.070 |
Why?
|
| Rheumatic Fever | 1 | 2006 | 9 | 0.070 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 31 | 0.070 |
Why?
|
| Young Adult | 3 | 2010 | 4012 | 0.070 |
Why?
|
| Cultural Characteristics | 1 | 2006 | 119 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 151 | 0.070 |
Why?
|
| HIV | 1 | 2006 | 97 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2011 | 541 | 0.070 |
Why?
|
| Polyomavirus | 1 | 2004 | 3 | 0.070 |
Why?
|
| Virology | 1 | 2004 | 7 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2005 | 53 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2013 | 628 | 0.060 |
Why?
|
| United States | 4 | 2020 | 3894 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 641 | 0.060 |
Why?
|
| HIV-1 | 1 | 2010 | 678 | 0.060 |
Why?
|
| Incidence | 3 | 2014 | 882 | 0.060 |
Why?
|
| Venous Insufficiency | 1 | 2003 | 2 | 0.060 |
Why?
|
| Leg Ulcer | 1 | 2003 | 7 | 0.060 |
Why?
|
| Leg | 1 | 2003 | 20 | 0.060 |
Why?
|
| Smoking | 2 | 2011 | 903 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2004 | 295 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2014 | 727 | 0.060 |
Why?
|
| Poverty | 1 | 2006 | 316 | 0.060 |
Why?
|
| Healthy People Programs | 1 | 2003 | 22 | 0.060 |
Why?
|
| Varicose Veins | 1 | 2002 | 1 | 0.060 |
Why?
|
| Virus Replication | 1 | 2004 | 261 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2002 | 30 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 18 | 0.050 |
Why?
|
| Catechin | 1 | 2002 | 30 | 0.050 |
Why?
|
| Tea | 1 | 2002 | 41 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2013 | 57 | 0.050 |
Why?
|
| Mortality | 1 | 2003 | 150 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2005 | 628 | 0.050 |
Why?
|
| Linear Models | 1 | 2002 | 253 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2018 | 1353 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2011 | 151 | 0.050 |
Why?
|
| Health Status | 1 | 2003 | 356 | 0.040 |
Why?
|
| Cholesterol | 1 | 2020 | 194 | 0.040 |
Why?
|
| Heart Rate | 2 | 2011 | 248 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 322 | 0.040 |
Why?
|
| Los Angeles | 1 | 2018 | 368 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 44 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 62 | 0.030 |
Why?
|
| Ideal Body Weight | 1 | 2014 | 4 | 0.030 |
Why?
|
| Diabetes Complications | 2 | 2006 | 91 | 0.030 |
Why?
|
| Child | 3 | 2007 | 2875 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 528 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 32 | 0.030 |
Why?
|
| Social Support | 2 | 2006 | 356 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 301 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2012 | 82 | 0.030 |
Why?
|
| Infant | 2 | 2007 | 1014 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 1003 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2007 | 1318 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2011 | 72 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2010 | 31 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 185 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2003 | 469 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 183 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2009 | 96 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1349 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 219 | 0.020 |
Why?
|
| Polynesia | 1 | 2008 | 7 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 125 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 213 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 228 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 295 | 0.020 |
Why?
|
| Hospitals, Rural | 1 | 2007 | 19 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 38 | 0.020 |
Why?
|
| Urban Health | 1 | 2007 | 86 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 570 | 0.020 |
Why?
|
| Tilt-Table Test | 1 | 2006 | 4 | 0.020 |
Why?
|
| Exercise | 1 | 2011 | 524 | 0.020 |
Why?
|
| Respiration | 1 | 2006 | 49 | 0.020 |
Why?
|
| Acute Disease | 1 | 2006 | 141 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 213 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 8 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2004 | 27 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 206 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2010 | 1961 | 0.020 |
Why?
|
| Veins | 1 | 2003 | 7 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2003 | 115 | 0.010 |
Why?
|
| Body Image | 1 | 2004 | 68 | 0.010 |
Why?
|
| Varicose Ulcer | 1 | 2002 | 1 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2003 | 57 | 0.010 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 229 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 223 | 0.010 |
Why?
|
| Cholesterol, VLDL | 1 | 2002 | 4 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Hydroxycholesterols | 1 | 2002 | 12 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2002 | 23 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 57 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 404 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 63 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 109 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 480 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 214 | 0.010 |
Why?
|
| Lipids | 1 | 2002 | 222 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1681 | 0.010 |
Why?
|
| Neoplasms | 1 | 2003 | 1033 | 0.010 |
Why?
|